Novo Nordisk Stock Plunges 15% After ‘CargiSema’ Fails To Match Eli Lilly’s Weight Loss Drug

by | February 23, 2026 8:20 pm | Latest Posts, Market, Trending News

“CargiSema could not achieve its primary endpoint of demonstrating non-inferiority on weight loss.”